Easton Capital joins £9M Cumulus Oncology investment round

Easton Capital has completed an investment in Cumulus Oncology alongside the Scottish National Investment Bank and a consortium of private investors led by Eos Advisory. The £9M equity investment will support Cumulus’s portfolio of companies dedicated to developing cancer treatments and fast-tracking the development of new drugs from discovery through clinical trials to patient application.

Founded in 2017 by CEO Dr Clare Wareing, Cumulus Oncology is a cancer therapeutics development company. Based in Edinburgh, it is Europe’s first biotech creation studio and drug discovery accelerator specialising in oncology. Cumulus takes a fresh approach to drug development as both the parent and creator of multiple spin-out companies.

Easton Capital provides long term capital investment to support high growth businesses. It is a division of the Easton Group – a family-owned property and investment business with 50 years’ experience of investing in our communities.


“We are very pleased to announce our investment in Cumulus Oncology, and proud to support its development of pioneering cancer treatments.

Cumulus has a unique business model that allows for the scientific validation of oncology therapies to be fast-tracked while de-risking the investment across a portfolio of assets.”

Steven Easton

Director at Easton Group


Easton Group News

Holyrood Distillery’s Bottle No. 1 sells for £8,000

Easton Capital backed Holyrood Distillery has launched its inaugural single malt whisky, Arrival, with the first bottle selling at auction for…

Read More

Double letting to Card Factory

Easton Property has agreed terms with national gift card retailer, Card Factory, for lease extensions at properties it owns in Montrose and…

Read More

Green Home Systems reach EY Entrepreneur Of The Year finals

The founders of Easton Capital portfolio company, Green Home Systems, have been shortlisted as Scotland finalists for the prestigious EY Entrepreneur…

Read More

View All News